FDA Asked to Approve Darzalex Triple Combo for Relapsed or Refractory Multiple Myeloma
News
Janssen has asked the U.S. Food and Drug Administration (FDA) to allow Darzalex (daratumumab) to also be used in combination with Kyprolis (carfilzomib) and dexamethasone to treat people with relapsed or refractory multiple myeloma ... Read more